Topical antibiotics for acne

Cochrane Database of Systematic Reviews

Volumn 2018, Issue 1, 2018, Pages

  Lazic Mosler, Elvira ^a,b,c   Leitner, Christina ^d   Gouda, Mohamed A ^e   Carter, Ben ^f   Layton, Alison M ^g   Khalafallah, Mahmoud Tawfik ^e  

^a Dr Ivo Pedi i General Hospital   (Croatia)

^b UNIVERSITY OF ZAGREB   (Croatia)

^c Croatian Academy of Medical Sciences Zagreb   (Croatia)

^d UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

^e MENOUFIA UNIVERSITY   (Egypt)

^f KING'S COLLEGE LONDON   (United Kingdom)

^g HARROGATE AND DISTRICT NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; PRIORITY JOURNAL; RETRACTED ARTICLE;

EID: 85040922197     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD012263.pub2     Document Type: Article

References (43)

1. Abdel Hay R, Shalaby K, Zaher H, Hafez V, Chi CC, Dimitri S, et al. Interventions for acne scars. Cochrane Database of Systematic Reviews 2016, Issue 4. [DOI: 10.1002/14651858.CD011946.pub2]
2. Arowojolu AO, Gallo MF, Lopez LM, Grimes DA. Combined oral contraceptive pills for treatment of acne. Cochrane Database of Systematic Reviews 2012, Issue 7. [DOI: 10.1002/14651858.CD004425.pub6]
3. Beylot C, Auffret N, Poli F, Claudel JP, Leccia MT, Del Giudice P, et al. Propionibacterium acnes: an update on its role in the pathogenesis of acne. Journal of the European Academy of Dermatology & Venereology 2014;28(3):271-278. [MEDLINE: 23905540]
4. Cao H, Yang G, Wang Y, Liu JP, Smith CA, Luo H, et al. Complementary therapies for acne vulgaris. Cochrane Database of Systematic Reviews 2015, Issue 1. [DOI: 10.1002/14651858.CD009436.pub2]
5. Cunliffe WJ, Holland DB, Jeremy A. Comedone formation: etiology, clinical presentation, and treatment. Clinics in Dermatology 2004;22(5):367-74. [MEDLINE: 15556720]
6. Del Rosso JQ, Leyden JJ, Thiboutot D, Webster GF. Antibiotic use in acne vulgaris and rosacea: clinical considerations and resistance issues of significance to dermatologists. Cutis 2008;82(2 Suppl 2):5-12. [MEDLINE: 18924545]
7. Drucker CR. Update on topical antibiotics in dermatology. Dermatologic Therapy 2012;25(1):6-11. [MEDLINE: 22591495]
8. Dutil M. Benzoyl peroxide: enhancing antibiotic efficacy in acne management. Skin Therapy Letter 2010;15(10):5-7. [MEDLINE: 21076800]
9. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. [MEDLINE: 9310563]
10. Gamble C, Hollis S. Uncertainty method improved on best-worst case analysis in a binary meta-analysis. Journal of Clinical Epidemiology 2005;58(6):579-88. [MEDLINE: 15878471]
11. Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM. Minocycline for acne vulgaris: efficacy and safety. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD002086.pub2]
12. Ghodsi SZ, Orawa H, Zouboulis CC. Prevalence, severity, and severity risk factors of acne in high school pupils: a community-based study. Journal of Investigative Dermatology 2009;129(9):2136-41. [MEDLINE: 19282841]
13. Gollnick H, Cunliffe W, Berson D, Dreno B, Finlay A, Leyden JJ, et al. Management of acne: a report from a Global Alliance to improve outcomes in acne. Journal of the American Academy of Dermatology 2003;49(1 Suppl):S1-37. [MEDLINE: 12833004]
14. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. Journal of the American Academy of Dermatology 1999;41(4):577-80. [MEDLINE: 10495379]
15. Goulden V, McGeown CH, Cunliffe WJ. The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals. British Journal of Dermatology 1999;141(2):297-300. [EMBASE: 1999296178]
16. Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP, Margolis DJ, et al. The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions. Journal of Investigative Dermatology 2014;134(6):1527-34. [PUBMED: 24166134]
17. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org. The Cochrane Collaboration.
18. Johnson BA, Nunley JR. Topical therapy for acne vulgaris. How do you choose the best drug for each patient?. Postgraduate Medicine 2000;107(3):69-70. [MEDLINE: 10728136]
19. Jordan R, Cummins C, Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence. British Journal of Dermatology 2000;142(3):413-23. [MEDLINE: 10735944]
20. Katsambas A, Dessinioti C. New and emerging treatments in dermatology: acne. Dermatologic Therapy 2008;21(2):86-95. [MEDLINE: 18394082]
21. Katsambas AD, Dessinioti C. Hormonal therapy for acne: why not as first line therapy? facts and controversies. Clinics in Dermatology 2010;28(1):17-23. [MEDLINE: 20082945]
22. Kinney MA, Yentzer BA, Fleischer AB Jr, Feldman SR. Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance?. Journal of Drugs in Dermatology 2010;9(5):519-24. [MEDLINE: 20480795]
23. Kurokawa I, Danby FW, Ju Q, Wang X, Xiang LF, Xia L, et al. New developments in our understanding of acne pathogenesis and treatment. Experimental Dermatology 2009;18(10):821-32. [MEDLINE: 19555434]
24. Layton AM, Henderson CA, Cunliffe WJ. A clinical evaluation of acne scarring and its incidence. Clinical & Experimental Dermatology 1994;19(4):303-8. [MEDLINE: 7955470]
25. Layton AM. Optimal management of acne to prevent scarring and psychological sequelae. American Journal of Clinical Dermatology 2001;2(3):135-41. [MEDLINE: 11705090]
26. Leyden JJ, Del Rosso JQ, Webster GF. Clinical considerations in the treatment of acne vulgaris and other inflammatory skin disorders: focus on antibiotic resistance. Cutis 2007;79(6 Suppl):9-25. [MEDLINE: 17649854]
27. Nast A, Dreno B, Bettoli V, Degitz K, Erdmann R, Finlay AY, et al. European evidence-based (S3) guidelines for the treatment of acne. Journal of the European Academy of Dermatology & Venereology 2012;26(Suppl 1):1-29. [MEDLINE: 22356611]
28. Ozolins M, Eady EA, Avery A, Cunliffe WJ, O'Neill C, Simpson NB, et al. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne. Health Technology Assessment 2005;9(1):iii-212. [MEDLINE: 15588555]
29. Patel M, Bowe WP, Heughebaert C, Shalita AR. The development of antimicrobial resistance due to the antibiotic treatment of acne vulgaris: a review. Journal of Drugs in Dermatology 2010;9(6):655-64. [MEDLINE: 20645527]
30. Simonart T, Dramaix M. Treatment of acne with topical antibiotics: lessons from clinical studies. British Journal of Dermatology 2005;153(2):395-403. [MEDLINE: 16086756]
31. Strauss JS, Krowchuk DP, Leyden JJ, Lucky AW, Shalita AR, Siegfried EC, et al. Guidelines of care for acne vulgaris management. Journal of the American Academy of Dermatology 2007;56(4):651-63. [MEDLINE: 17276540]
32. Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opinion in Pharmacotherapy 2005;6(3):409-18. [MEDLINE: 15794732]
33. Thiboutot D. Acne: hormonal concepts and therapy. Clinics in Dermatology 2004;22(5):419-28. [MEDLINE: 15556729]
34. Thiboutot D, Gollnick H, Bettoli V, Dréno B, Kang S, Leyden JJ, et al. New insights into the management of acne: an update from the Global Alliance to improve outcomes in acne group. Journal of the American Academy of Dermatology 2009;60(5 Suppl):S1-50. [MEDLINE: 19376456]
35. Van Zuuren EJ, Fedorowicz Z, Carter B, Pandis N. Interventions for hirsutism (excluding laser and photoepilation therapy alone). Cochrane Database of Systematic Reviews 2015, Issue 4. [DOI: 10.1002/14651858.CD010334.pub2]
36. Vlassova N, Han A, Zenilman JM, James G, Lazarus GS. New horizons for cutaneous microbiology: the role of biofilms in dermatological disease. British Journal of Dermatology 2011;165(4):751-9. [MEDLINE: 21668434]
37. Webster GF, McGinley KJ, Leyden JJ. Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin. British Journal of Dermatology 1981;104(4):453-457. [MEDLINE: 6786318]
38. Williams C, Layton AM. Persistent acne in women: implications for the patient and for therapy. American Journal of Clinical Dermatology 2006;7(5):281-90. [MEDLINE: 17007539]
39. Williams HC, Dellavalle RP, Garner S. Acne vulgaris. Lancet 2012;379(9813):361-72. [MEDLINE: 21880356]
40. Worret WI, Fluhr JW. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid [Topische Therapie mit Benzoylperoxid, Antibiotika und Azelainsäurebei der Akne]. Journal der Deutschen Dermatologischen Gesellschaft 2006;4(4):293-300. [MEDLINE: 16638058]
41. Zouboulis CC. Acne and sebaceous gland function. Clinics in Dermatology 2004;22(5):360-6. [MEDLINE: 15556719]
42. Zouboulis CC, Eady A, Philpott M, Goldsmith LA, Orfanos C, Cunliffe WC, et al. What is the pathogenesis of acne?. Experimental Dermatology 2005;14(2):143-52. [MEDLINE: 15679586]
43. Zouboulis CC. Acne as a chronic systemic disease. Clinical Dermatology 2014;32(3):389-96. [PUBMED: 24767186]